FiercePharma  May 27  Comment 
Sanders chastises U.S. reps over role in Gleevec CL battle ewasserman Fri, 05/27/2016 - 08:45
The Economic Times  May 27  Comment 
Company said its standalone total income from operations stood at Rs 167.27 cr for Q4, compared with Rs 207.64 cr in the corresponding period of last year.
The Hindu Business Line  May 27  Comment 
Shares of drug firm Novartis India today slumped 13 per cent as investors were disappointed over Q4 results. The stock tumbled 13 per cent to Rs 720 on the BSE. Novartis India had yesterday repo...
GenEng News  May 27  Comment 
PDL BioPharma has acquired exclusive worldwide rights to two antihypertension drugs from Novartis through an investment in a new majority-owned subsidiary. PDL said yesterday it will invest up to $294 million in the subsidiary, Noden Pharma...
The Hindu Business Line  May 26  Comment 
Pharma major looking to purchase 3,820,000 shares for about ₹290 crore
newratings.com  May 26  Comment 
BRUSSELS (dpa-AFX) - The Swiss stock market continued its upward trend Thursday, rising for the fifth consecutive trading session. The market received support from the positive performance of index heavyweights Nestle and Novartis. Rising crude...
FiercePharma  May 26  Comment 
Tug-of-war over Novartis' Gleevec rights in Colombia escalates with U.S. lawmakers' challenge ewasserman Thu, 05/26/2016 - 09:14
Benzinga  May 25  Comment 
Switzerland-based Novartis AG (ADR) (NYSE: NVS) owns a roughly $14 billion stake in rival Roche Holding Ltd. (ADR) (OTC: RHHBY) and is actively shopping for buyers to acquire its stake. According to Reuters, Novartis has been working with...
FierceBiotech  May 25  Comment 
Novartis goes after Roche’s biggest earner Rituxan in Europe badams Wed, 05/25/2016 - 06:44
newratings.com  May 25  Comment 
BASEL (dpa-AFX) - Novartis International AG (NVS) said its management has reiterated commitment to growth with margin expansion for Sandoz division. The division has said it would announce a total of 10 new filings between 2015 and 2017. Six have...


Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki